Inverness To Distribute Vedalab Tests Under Patent Settlement
This article was originally published in The Gray Sheet
Executive Summary
Inverness Medical Innovations gains distribution rights to French firm Vedalab's current and future products, including over-the-counter pregnancy tests as well as prostate-specific antigen tests, under a patent litigation settlement reached Nov. 16
You may also be interested in...
Chembio Clears Path For HIV Tests With Patent, Marketing Agreement
Chembio settled its legal disputes and found a marketing partner for its recently approved rapid HIV tests in a three-party agreement announced Oct. 5
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.